🔎 Trials Near Me

Home › Triple-Negative Breast Cancer › South Carolina › Charleston

Triple-Negative Breast Cancer clinical trials in Charleston, SC

6 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

RecruitingPhase 3
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06966700

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

RecruitingPhase 2
  • Medical University of South Carolina Hollings Cancer Center,, Charleston
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07743190

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

RecruitingPhase 1
  • Normunity Investigational Site, Charleston
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149

NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients

RecruitingPhase 2
  • Medical University of South Carolina, Charleston
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06845319

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

RecruitingPhase 2
  • Medical University of South Carolina, Charleston
Ages 18 and older · All sexes · Updated Apr 29, 2026 · NCT04468061

Triple-Negative Breast Cancer trials in other cities

Other studies in Charleston

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.